Tovorafenib (DAY101)

tovorafenib · Day One Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tovorafenib (DAY101), covering 2024-08-12 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis [Phase 2]

See pricing